跳至主要内容
临床试验/NCT04453956
NCT04453956Unknown不适用

A Prospective, Randomized, Single-blind, 2 × 2 Factorial Design Single Center Study Evaluating the Polyp Detection and Quality Monitoring Function of EndoAngel in Improving the Quality of Colonoscopy

Renmin Hospital of Wuhan University1 个研究点 分布在 1 个国家目标入组 1,090 人开始时间: 2020年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
1,090
试验地点
1
主要终点
Adenoma detection rate

研究概览

简要总结

An artificial intelligence-based system, named EndoAngel,has been constructed previously,which has polyp detection and quality monitoring functions. This study aims to evaluate the two different functions of EndoAngle in improving adenoma detection rate.

详细描述

The detection and removal of precancerous polyps via colonoscopy can reduce the the risk of colon cancer. However, the detection rate of adenomatous polyps can vary significantly among endoscopists. EndoAngel is an artificial intelligence-based system,consisting of polyp detection and quality monitoring functions. The polyp detection function can remind endoscopists of the location of the polyp. The quality monitoring function can monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.This study aims to evaluate the two different functions of EndoAngle by 2 × 2 factorial design in improving adenoma detection rate and the quality of colonscopy .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Diagnostic
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Male or female aged 18 years or above;
  • •Colonoscopy is needed to further characterize gastrointestinal diseases;
  • •Ability to read, understand and sign informed consent forms;
  • •The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures.

排除标准

  • •Participated in other clinical trials, signed informed consent forms and followed up in other clinical trials;
  • •Participate in a drug clinical trial and during the elution period of the trial or control drug;
  • •Drug or alcohol abuse or mental disorder in the last 5 years;
  • •Pregnant or lactating women;
  • •Patients with multiple polyp syndrome;
  • •Patients with a history of inflammatory bowel disease, colorectal cancer, or colorectal surgery;
  • •Patients with known perforation or colonic obstruction;
  • •Patients with a contraindication for biopsy;
  • •The researchers did not consider the subjects suitable for colonoscopy;
  • •The researchers determined that the subjects had high-risk diseases or other special conditions that were not appropriate for clinical trials.

研究组 & 干预措施

Control group

Sham Comparator

Patients will receive colonoscopy without assistance of EndoAngel's any function.

干预措施: Colonoscopy without the assistance of EndoAngel's any function. (Diagnostic Test)

Polyp detection function group

Experimental

Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection function.

干预措施: Colonoscopy with the assistance of EndoAngel's polyp detection function. (Diagnostic Test)

Quality monitoring function group

Experimental

Patients will receive colonoscopy with the assistance of EndoAngel's quality monitoring function.

干预措施: Colonoscopy with the assistance of EndoAngel's quality monitoring function. (Diagnostic Test)

Polyp detection plus quality monitoring functions group

Experimental

Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection plus quality monitoring function.

干预措施: Colonoscopy with the assistance of EndoAngel's polyp detection function. (Diagnostic Test)

Polyp detection plus quality monitoring functions group

Experimental

Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection plus quality monitoring function.

干预措施: Colonoscopy with the assistance of EndoAngel's quality monitoring function. (Diagnostic Test)

结局指标

主要结局

Adenoma detection rate

时间窗: 3 Months

The numerator is the number of cases of adenomas detected by colonoscopy, and the denominator is the total number of cases of patients undergoing colonoscopy.

次要结局

  • Cecal intubation rate(3 months)
  • The mean number of polyps per procedure(3 months)
  • The mean number of adenomas per procedure(3 months)
  • The mean number of large, small and diminutive adenomas per procedure(3 months)
  • The mean number of adenomas in different sites per procedure(3 months)
  • Time of colonoscopic insertion(3 months)
  • Time of colonoscopic withdrawal(3 months)
  • Polyp detection rate(3 months)
  • Detection rate of adenoma in different sites(3 months)
  • Detection rate of large, small and diminutive polyps(3 months)
  • The mean number of large, small and diminutive polyps per procedure(3 months)
  • Detection rate of large, small and diminutive adenomas(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Unknown
2 期
Safety, Pharmacokinetics, Pharmacodynamics and Efficacy study of MRG-001 on Severe and Critical SARS-CoV-2
CTRI/2022/01/039274Medregen LLC
进行中(未招募)
1 期
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis PaiKnee osteoarthritis painMedDRA version: 21.1Level: LLTClassification code: 10023476Term: Knee osteoarthritis Class: 10028395
CTIS2022-500228-31-00Paradigm Biopharmaceuticals (USA) Inc.898
进行中(未招募)
1 期
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis PaiKnee osteoarthritis painMedDRA version: 21.1Level: LLTClassification code: 10023476Term: Knee osteoarthritis Class: 10028395
CTIS2022-500228-31-01Paradigm Biopharmaceuticals (USA) Inc.938
已完成
1 期
A study of a new drug, NPI-001 in healthy volunteers to test its safety and tolerabilityRetinitis pigmentosa (RP)
ACTRN12617000911392acuity Pharmaceuticals Pty Ltd54
进行中(未招募)
1 期
A Phase II/III study of GSK3359609 in combination with pembrolizumab compared with pembrolizumab plus placebo in participants with recurrent or metastatic head and neck cancerRecurrent/Metastatic Head and Neck Squamous Cell CarcinomaMedDRA version: 21.1Level: LLTClassification code 10065147Term: Malignant solid tumorSystem Organ Class: 100000004864
EUCTR2019-002263-99-HUGlaxoSmithKline Research & Development Ltd600